- Home
- RENT vs MTVA Comparison
RENT vs MTVA Comparison
Compare RENT & MTVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RENT
- MTVA
- Stock Information
- Founded
- RENT 2009
- MTVA 2014
- Country
- RENT United States
- MTVA United States
- Employees
- RENT N/A
- MTVA N/A
- Industry
- RENT Other Specialty Stores
- MTVA
- Sector
- RENT Consumer Discretionary
- MTVA
- Exchange
- RENT Nasdaq
- MTVA NYSE
- Market Cap
- RENT 16.7M
- MTVA 7.1M
- IPO Year
- RENT 2021
- MTVA N/A
- Fundamental
- Price
- RENT $4.21
- MTVA $0.71
- Analyst Decision
- RENT Strong Buy
- MTVA Strong Buy
- Analyst Count
- RENT 2
- MTVA 1
- Target Price
- RENT $33.00
- MTVA $12.00
- AVG Volume (30 Days)
- RENT 58.1K
- MTVA 1.5M
- Earning Date
- RENT 06-05-2025
- MTVA 05-20-2025
- Dividend Yield
- RENT N/A
- MTVA N/A
- EPS Growth
- RENT N/A
- MTVA N/A
- EPS
- RENT N/A
- MTVA N/A
- Revenue
- RENT $306,200,000.00
- MTVA N/A
- Revenue This Year
- RENT N/A
- MTVA N/A
- Revenue Next Year
- RENT $2.72
- MTVA N/A
- P/E Ratio
- RENT N/A
- MTVA N/A
- Revenue Growth
- RENT 2.68
- MTVA N/A
- 52 Week Low
- RENT $3.69
- MTVA $0.71
- 52 Week High
- RENT $41.81
- MTVA $5.30
- Technical
- Relative Strength Index (RSI)
- RENT 46.51
- MTVA N/A
- Support Level
- RENT $3.69
- MTVA N/A
- Resistance Level
- RENT $4.54
- MTVA N/A
- Average True Range (ATR)
- RENT 0.34
- MTVA 0.00
- MACD
- RENT 0.01
- MTVA 0.00
- Stochastic Oscillator
- RENT 58.37
- MTVA 0.00
About RENT Rent the Runway Inc.
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories. It gives customers access to its unlimited closet through its subscription offering (Subscription) or the ability to rent a-la-carte through its reserve offering (Reserve). The company also gives its subscribers and customers the ability to buy its products through its Resale offering. Its Closet in the Cloud offers a wide assortment of items for every occasion, from evening wear and accessories to ready-to-wear, workwear, denim, casual, maternity, outerwear, blouses, knitwear, loungewear, jewelry, handbags, activewear and ski wear.
About MTVA METAVIA INC
MetaVia Inc Formerly NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.